Optimal population of FoxP3 + t cells in tumors requires an antigen priming-dependent trafficking receptor switch

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wang, Chuanwu ^a   Lee, Jee H ^a   Kim, Chang H ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CXCR4; HELIOS ANTIGEN; L SELECTIN; LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR; DNA BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; ZFPN1A2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN PRIMING; ARTICLE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; LYMPH NODE CELL; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR VOLUME; UPREGULATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; IMMUNOGENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGENETIC PROCESSES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 84856101841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030793     Document Type: Article

References (59)

1. Tang Q, Bluestone JA, (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9: 239-244.
2. Stephens GL, Shevach EM, (2007) Foxp3+ regulatory T cells: selfishness under scrutiny. Immunity 27: 417-419.
3. Zheng Y, Rudensky AY, (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8: 457-462.
4. Campbell DJ, Ziegler SF, (2007) FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 7: 305-310.
5. Kim CH, (2006) Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system. Exp Hematol 34: 1033-1040.
6. Miyara M, Sakaguchi S, (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116.
7. Lee JH, Kang SG, Kim CH, (2007) FoxP3+ T Cells Undergo Conventional First Switch to Lymphoid Tissue Homing Receptors in Thymus but Accelerated Second Switch to Nonlymphoid Tissue Homing Receptors in Secondary Lymphoid Tissues. J Immunol 178: 301-311.
8. Awwad M, North RJ, (1988) Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J Exp Med 168: 2193-2206.
9. North RJ, Bursuker I, (1984) Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J Exp Med 159: 1295-1311.
10. North RJ, (1982) Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155: 1063-1074.
11. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, et al. (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133.
12. Shimizu J, Yamazaki S, Sakaguchi S, (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211-5218.
13. Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, et al. (2007) The impact of regulatory T cells on carcinogen-induced sarcogenesis. Br J Cancer 96: 1849-1854.
14. Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, et al. (2003) CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 171: 5931-5939.
15. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, et al. (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A 102: 419-424.
16. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
17. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, et al. (2005) The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11: 8326-8331.
18. Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, et al. (2007) Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13: 2075-2081.
19. Alvaro T, Lejeune M, Salvado MT, Bosch R, Garcia JF, et al. (2005) Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11: 1467-1473.
20. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, et al. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108: 2957-2964.
21. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, et al. (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12: 465-472.
22. Salama P, Phillips M, Grieu F, Morris M, Zeps N, et al. (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27: 186-192.
23. Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, et al. (2008) Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 98: 148-153.
24. Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, et al. (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69: 2000-2009.
25. Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, et al. (2008) Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood 111: 5359-5370.
26. Baumgartner J, Wilson C, Palmer B, Richter D, Banerjee A, et al. (2007) Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells. J Surg Res 141: 72-77.
27. Liu VC, Wong LY, Jang T, Shah AH, Park I, et al. (2007) Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178: 2883-2892.
28. Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, et al. (2005) Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res 65: 5211-5220.
29. Lutsiak ME, Tagaya Y, Adams AJ, Schlom J, Sabzevari H, (2008) Tumor-induced impairment of TCR signaling results in compromised functionality of tumor-infiltrating regulatory T cells. J Immunol 180: 5871-5881.
30. Xu L, Xu W, Wen Z, Xiong S, (2011) In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-beta secreting DCs is crucial for their enrichment and suppression in tumor immunity. PLoS One 6: e20282.
31. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10: 1000-1007.
32. Moore MW, Carbone FR, Bevan MJ, (1988) Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
33. Wang C, Kang SG, HogenEsch H, Love PE, Kim CH, (2010) Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine. J Immunol 184: 5519-5526.
34. Wang C, Kang SG, Lee J, Sun Z, Kim CH, (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2: 173-183.
35. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
36. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW, (2011) Helios expression is a marker of T cell activation and proliferation. PLoS One 6: e24226.
37. Lee J, Kang SG, Kim CH, (2006) FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to non-lymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol Pending.
38. Ziegler SF, (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
39. Kim CH, (2009) FOXP3 and its role in the immune system. Adv Exp Med Biol 665: 17-29.
40. Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, et al. (2008) CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 205: 1975-1981.
41. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
42. Nishikawa H, Sakaguchi S, (2010) Regulatory T cells in tumor immunity. Int J Cancer 127: 759-767.
43. Mailloux AW, Young MR, (2009) NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment. J Immunol 182: 2753-2765.
44. Tan MC, Goedegebuure PS, Belt BA, Flaherty B, Sankpal N, et al. (2009) Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 182: 1746-1755.
45. Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, et al. (2008) CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int J Cancer 122: 2286-2293.
46. Ishida T, Ishii T, Inagaki A, Yano H, Komatsu H, et al. (2006) Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 66: 5716-5722.
47. Valzasina B, Piconese S, Guiducci C, Colombo MP, (2006) Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res 66: 4488-4495.
48. Moo-Young TA, Larson JW, Belt BA, Tan MC, Hawkins WG, et al. (2009) Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. J Immunother 32: 12-21.
49. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
50. Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH, (2007) Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T Cells. J Immunol 179: 3724-3733.
51. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
52. Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc'h N, et al. (2005) Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 175: 1483-1490.
53. Lee JH, Ulrich B, Cho J, Park J, Kim CH, (2011) Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into th17 cells. J Immunol 187: 1778-1787.
54. Ben-Shoshan J, Maysel-Auslender S, Mor A, Keren G, George J, (2008) Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38: 2412-2418.
55. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. (2011) Control of T(H)17/T(reg) Balance by Hypoxia-Inducible Factor 1. Cell 146: 772-784.
56. Shi LZ, Wang R, Huang G, Vogel P, Neale G, et al. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208: 1367-1376.
57. Elkord E, Sharma S, Burt DJ, Hawkins RE, (2011) Expanded subpopulation of FoxP3(+) T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. Clin Immunol 140: 218-222.
58. Wald O, Izhar U, Amir G, Avniel S, Bar-Shavit Y, et al. (2006) CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma. J Immunol 177: 6983-6990.
59. Kim CH, (2005) The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr Opin Hematol 12: 298-304.